Acurx Pharmaceuticals Inc’s recently made public that its Director Scodari Joseph C acquired Company’s shares for reported $25000.0 on Jan 06 ’25. In the deal valued at $1.01 per share,24,631 shares were bought. As a result of this transaction, Scodari Joseph C now holds 27,708 shares worth roughly $23551.8.
Then, Sailer Carl bought 24,631 shares, generating $25,000 in total proceeds. Upon buying the shares at $1.01, the Director now owns 137,183 shares.
Before that, LUCI DAVID P bought 49,261 shares. Acurx Pharmaceuticals Inc shares valued at $50,000 were divested by the President and CEO at a price of $1.01 per share. As a result of the transaction, LUCI DAVID P now holds 1,097,458 shares, worth roughly $0.93 million.
Price Performance Review of ACXP
On Friday, Acurx Pharmaceuticals Inc [NASDAQ:ACXP] saw its stock jump 8.33% to $0.85. Over the last five days, the stock has gained 14.26%. Acurx Pharmaceuticals Inc shares have risen nearly 4.15% since the year began. Nevertheless, the stocks have fallen -71.26% over the past one year. While a 52-week high of $3.35 was reached on 01/06/25, a 52-week low of $0.67 was recorded on 02/20/25. SMA at 50 days reached $0.8065, while 200 days put it at $1.7296.
Levels Of Support And Resistance For ACXP Stock
The 24-hour chart illustrates a support level at 0.7367, which if violated will result in even more drops to 0.6255. On the upside, there is a resistance level at 0.9045. A further resistance level may holdings at 0.9611. The Relative Strength Index (RSI) on the 14-day chart is 56.13, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0105, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 1.22%. Stochastics %K at 60.96% indicates the stock is a holding.
